Soluble CD40L stimulation human peripheral blood B cell long-period culture method
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE AFFILIATED DRUM TOWER HOSPITAL MEDICAL SCHOOL OF NANJING UNIV
- Publication Date
- 2011-06-01
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a cell culture method, in particular to a long-term culture method using soluble CD40 ligand (sCD40L) to stimulate human peripheral blood B cells. Background technique
[0002] In the field of anti-HBV-specific active immunotherapy, dendritic cells (DC), as a powerful antigen-presenting cell (APC), play a central role in anti-viral immunity. Scientific research has proved that DC functional defects or reduced numbers are directly related to chronic hepatitis B or chronic carrier status. Therefore, the use of activated DC can induce HBsAg-specific killing effect, which is a very promising method for active immunotherapy against hepatitis virus. However, this method has the following defects: (1) the number of dendritic cells is very small in a natural state, only accounting for 0.1%-0.5% of peripheral blood mononuclear cells, and it is difficult to culture in vitro, and the survival time is short. In 10-15 days, the number of ...